Hot penny stocks... don't get burned
   

News for Ym Biosciences, Inc (YMI)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for YM BioSciences Inc.  (YMI) 
|
$ 0.588    0.00 (0.00%) Volume: 0 3:59 PM EDT Sep 5, 2008
Tue, Aug 05, 2008
11:44 AM YM BIOSCIENCES ANNOUNCES STAFFING CHANGES - Canada NewsWire
9:46 AM NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER - PR Newswire
9:46 AM NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER - Canada NewsWire
Mon, Aug 04, 2008
7:24 PM YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER - PR Newswire
7:23 PM YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER - Canada NewsWire
Mon, Jul 21, 2008
5:04 PM YM BIOSCIENCES PRESENTS DATA COMPARING MECHANISM OF ACTION FOR EGFR ANTIBODY, NIMOTUZUMAB TO CETUXIMAB AND PANITUMUMAB, AT THE AACR CENTENNIAL CONFERENCE ON TRANSLATIONAL CANCER MEDICINE 2008 - Canada NewsWire
Tue, Jul 08, 2008
6:45 PM Wall Street Media Presents Exclusive Videos from the Collins Stewart Fourth Annual Growth Conference - Business Wire
Thu, Jun 19, 2008
5:00 PM YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL - PR Newswire
5:00 PM YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL - Canada NewsWire
Tue, Jun 03, 2008
1:57 PM NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING - PR Newswire
Mon, Jun 02, 2008
11:21 AM NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING - Canada NewsWire
7:01 AM YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING - PR Newswire
7:00 AM YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING - Canada NewsWire
Thu, May 08, 2008
8:56 PM YM BIOSCIENCES REPORTS FISCAL THIRD QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS - Canada NewsWire
Mon, May 05, 2008
5:21 PM YM BIOSCIENCES ANNOUNCES SCHEDULE OF NIMOTUZUMAB PRESENTATIONS AT ASCO 2008 ANNUAL MEETING - Canada NewsWire
1:00 AM YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING - PR Newswire
1:00 AM YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING - Canada NewsWire
Fri, Apr 11, 2008
5:07 PM YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING - PR Newswire
5:07 PM YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING - Canada NewsWire
Wed, Feb 13, 2008
7:00 AM YM BIOSCIENCES USA ENROLLS FIRST PATIENT IN PHASE II TRIAL OF NIMOTUZUMAB IN CHILDREN WITH INOPERABLE, RECURRENT BRAIN CANCER - Canada NewsWire
Thu, Feb 07, 2008
7:00 AM YM BIOSCIENCES REPORTS SECOND QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS - Canada NewsWire
Fri, Jan 18, 2008
5:00 PM YM BIOSCIENCES SHAREHOLDING IN COMPANY - Canada NewsWire
Thu, Jan 17, 2008
1:00 AM YM BioSciences provides update on AeroLEF(TM) clinical development program - PR Newswire
1:00 AM YM BioSciences provides update on AeroLEF(TM) clinical development program - Canada NewsWire
Thu, Dec 20, 2007
11:16 AM YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB COLORECTAL CANCER TRIAL FIRST COHORT IS CLOSED TO ACCRUAL - PR Newswire
  Page 1 of 3   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMediaTerms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for YMI stock. Download YMI report.
Research Report
Get the full report for FREE
Date:Sep 4, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download YMI report
  
Example preview: Research report for Ym Biosciences, Inc (YMI) Research report for Ym Biosciences, Inc (YMI) Research report for Ym Biosciences, Inc (YMI) Research report for Ym Biosciences, Inc (YMI)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   

SPKL shot up 21%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Ym Biosciences, Inc